デュプイトレン病の世界市場レポート 2025年

デュプイトレン病の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.0％で、57億6,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、治療オプションの進歩、認知度の向上と早期診断、ヘルスケア支出の増加、低侵襲手技の採用増加、研究開発活動の拡大などの要因によるものです。この期間の主な動向には、遺伝子治療における画期的な進歩、再生医療と幹細胞治療の進歩、AIを活用した診断ツールの革新、カスタム装具のための3Dプリンティングの進歩、低侵襲手術手技の継続的な開発などが含まれます。

低侵襲治療の人気の高まりがデュプイトレン病市場の成長を牽引すると予想されます。これらの治療は最小限の切開や組織損傷で行われ、痛みの緩和や傷跡の減少につながります。従来の手術に比べ、回復が早く、不快感が少なく、合併症のリスクも低いため、患者が低侵襲の選択肢を選ぶケースが増えています。これらの治療は、手の機能を回復させ、拘縮を軽減し、より早く快適な回復を保証することで、デュプイトレン病患者を効果的に支援しています。例えば、2023年6月の王立オーストラレーシア外科大学（RACS）の報告によると、オーストラリアでダヴィンチプラットフォームを使用して行われた手術は12％増加し、2021年の1万7,852件から2022年には1万9,989件に増加しました。その結果、低侵襲治療の利用拡大がデュプイトレン病市場拡大の主要因となっています。

デュプイトレン病市場の主要企業は、新規の第一選択疾患修飾治療法を開発するために臨床試験に注力しています。臨床試験は、新しい治療法、薬剤、処置の安全性、有効性、潜在的な副作用を評価するために実施されます。2023年4月、Ventoux Biosciences（米国）は、米国人口の約5％が罹患しているデュプイトレン拘縮をターゲットとした線維症治療薬の前臨床試験で良好な結果が得られたと発表しました。同社の主要候補であるVEN-201は、市販されている薬剤を再利用したもので、マウスモデルにおいて皮膚の線維化を抑制する効果を示しました。この有望な結果を受けて、Ventoux社はVEN-201の開発を支援するための資金調達ラウンドを開始しました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のデュプイトレン病市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のデュプイトレン病市場：成長率分析
• 世界のデュプイトレン病市場の実績：規模と成長、2019～2024年
• 世界のデュプイトレン病市場の予測：規模と成長、2024～2029年、2034年
• 世界のデュプイトレン病総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のデュプイトレン病市場：疾患タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• タイプI
• タイプII
• タイプIII
• 世界のデュプイトレン病市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
• 手術
• 放射線治療
• 針腱膜切開術
• ステロイド注射
• 酵素注射
• 作業療法
• その他
• 世界のデュプイトレン病市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 非経口
• その他
• 世界のデュプイトレン病市場：診断別、実績と予測、2019～2024年、2024～2029年、2034年
• 身体検査
• X線
• その他
• 世界のデュプイトレン病市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 学術研究機関
• その他
• 世界のデュプイトレン病市場：タイプIのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 古典型デュプイトレン病
• 家族性デュプイトレン病
• 世界のデュプイトレン病市場：タイプIIのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 掌側筋膜炎
• レダーホース病
• 世界のデュプイトレン病市場：タイプIIIのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ガロッドパッド
• ペロニー病

第7章 地域別・国別分析

• 世界のデュプイトレン病市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のデュプイトレン病市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• デュプイトレン病市場：競合情勢
• デュプイトレン病市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Aetna Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Mayo clinic Overview, Products and Services, Strategy and Financial Analysis
  • Penn Medicine Overview, Products and Services, Strategy and Financial Analysis
  • Mercy Health Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Endo Inc.
• Resilience Orthopedics
• Raleigh Orthopaedic
• Hoag Orthopedic Institute
• OSS Health
• Connext Inc.
• University of Utah Health
• Ventoux Biosciences Inc.
• Auxilium Pharmaceuticals
• 31.11. Brigid Freyne MD
• 31.12. Nantong Jinghua Pharmaceutical Co. Ltd.
• 31.13. Sumitomo Dainippon Pharma Co. Ltd.
• 31.14. Actiza Pharmaceutical Private Limited
• 31.15. Spear Pharmaceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• デュプイトレン病市場2029：新たな機会を提供する国
• デュプイトレン病市場2029：新たな機会を提供するセグメント
• デュプイトレン病市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Dupuytren's disease, also known as Dupuytren's contracture, is a condition that affects the connective tissue (fascia) in the palm and fingers, leading to thickening and tightening. Over time, this causes the fingers to bend toward the palm, making it difficult to straighten them or perform daily tasks.

The primary types of Dupuytren's disease include Type I, Type II, and Type III. Type I is the most severe form and typically appears in individuals younger than 50. Treatment options include surgery, radiation therapy, needle aponeurotomy, steroid injections, enzyme injections, and occupational therapy, among others. These treatments can be administered through various routes, such as oral or parenteral methods. Diagnosis is conducted through physical examinations, X-rays, and other medical assessments. The condition is managed across various end-users, including hospitals, clinics, academic and research institutions, and other healthcare facilities.

The dupuytren's disease market research report is one of a series of new reports from The Business Research Company that provides dupuytren's disease market statistics, including the dupuytren's disease industry global market size, regional shares, competitors with the dupuytren's disease market share, detailed dupuytren's disease market segments, market trends, and opportunities, and any further data you may need to thrive in the dupuytren's disease industry. This dupuytren's disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The dupuytren's disease market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth observed in the historical period can be attributed to factors such as a growing aging population, a higher genetic predisposition, an increasing prevalence of diabetes, rising alcohol consumption, and a greater incidence of manual labor and repetitive hand trauma.

The dupuytren's disease market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth expected during the forecast period can be attributed to factors such as advancements in treatment options, greater awareness and earlier diagnosis, rising healthcare spending, increased adoption of minimally invasive procedures, and expanding research and development activities. Key trends during this period include breakthroughs in gene therapy, advancements in regenerative medicine and stem cell therapy, innovations in AI-driven diagnostic tools, progress in 3D printing for custom orthotics, and continued development of minimally invasive surgical techniques.

The increasing popularity of minimally invasive treatments is expected to drive the growth of the Dupuytren's disease market. These treatments are performed with minimal incisions or tissue damage, leading to pain relief and reduced scarring. Patients are increasingly choosing minimally invasive options because they offer quicker recovery, less discomfort, and a lower risk of complications compared to traditional surgery. These treatments effectively help Dupuytren's disease patients by restoring hand function, reducing contractures, and ensuring a faster, more comfortable recovery. For example, a report from the Royal Australasian College of Surgeons (RACS) in June 2023 revealed a 12% increase in procedures performed using da Vinci platforms in Australia, rising from 17,852 in 2021 to 19,989 in 2022. As a result, the growing use of minimally invasive treatments is a key driver of the Dupuytren's disease market expansion.

Leading companies in the Dupuytren's disease market are focusing on clinical trials to develop novel, first-line, disease-modifying treatments. Clinical trials are conducted to assess the safety, effectiveness, and potential side effects of new medical treatments, drugs, or procedures before they are approved for widespread use. In April 2023, Ventoux Biosciences, a US-based biopharmaceutical company focused on developing non-surgical therapies for Dupuytren's disease, announced positive pre-clinical results for its fibrosis treatment targeting Dupuytren's contracture, which affects approximately five percent of the U.S. population. The company's lead candidate, VEN-201, is a repurposed commercially available drug that has shown effectiveness in reducing skin fibrosis in mouse models. This promising outcome led Ventoux to initiate a fundraising round to support the development of VEN-201.

In November 2024, John Elway, a US-based retail company, partnered with Endo Inc. to raise awareness and encourage early diagnosis and treatment of Dupuytren's contracture. The partnership aims to promote XIAFLEX (collagenase clostridium histolyticum) as a non-surgical treatment option for the condition. Endo Inc., a US-based pharmaceutical company, manufactures this medication for Dupuytren's contracture. The collaboration seeks to improve patient outcomes through better awareness and access to treatment options.

Major players in the dupuytren's disease market are Pfizer Inc., Aetna Inc., Mayo clinic, Penn Medicine, Mercy Health, Endo Inc., Resilience Orthopedics, Raleigh Orthopaedic, Hoag Orthopedic Institute, OSS Health, Connext Inc., University of Utah Health, Ventoux Biosciences Inc., Auxilium Pharmaceuticals, 180 Life Sciences Corp., Brigid Freyne MD, Nantong Jinghua Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Actiza Pharmaceutical Private Limited, Spear Pharmaceuticals.

North America was the largest region in the dupuytren's disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dupuytren's disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dupuytren's disease market consists of revenues earned by entities by providing services such as diagnosis, physical therapy, minimally invasive treatments, surgical procedures, post-treatment rehabilitation, and related pharmaceutical and medical device solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The dupuytren's disease market also includes sales of products such as collagenase injections, anti-inflammatory medications, splints, orthopedic braces, surgical instruments, and laser or ultrasound therapy devices used for treatment and management of the condition. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dupuytren's Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dupuytren's disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dupuytren's disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dupuytren's disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Type I; Type II; Type III
• 2) By Treatment: Surgery; Radiation Therapy; Needle Aponeurotomy; Steroid Shot; Enzyme Injection; Occupational Therapy; Other Treatments
• 3) By Route of Administration: Oral; Parenteral; Other Routes Of Administration
• 4) By Diagnosis: Physical Examination; X-Ray; Other Diagnosis
• 5) By End-User: Hospitals; Clinics; Academic And Research Institute; Other End-Users
• Sub Segments:
• 1) By Type I: Classical Dupuytren's Disease; Familial Dupuytren's Disease
• 2) By Type II: Palmar Fasciitis; Ledderhose Disease
• 3) By Type III: Garrod's Pads; Peyronie's Disease
• Companies Mentioned: Pfizer Inc.; Aetna Inc.; Mayo clinic; Penn Medicine; Mercy Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dupuytren's Disease Market Characteristics

3. Dupuytren's Disease Market Trends And Strategies

4. Dupuytren's Disease Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Dupuytren's Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Dupuytren's Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Dupuytren's Disease Market Growth Rate Analysis
• 5.4. Global Dupuytren's Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Dupuytren's Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Dupuytren's Disease Total Addressable Market (TAM)

6. Dupuytren's Disease Market Segmentation

• 6.1. Global Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Type I
• Type II
• Type III
• 6.2. Global Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Radiation Therapy
• Needle Aponeurotomy
• Steroid Shot
• Enzyme Injection
• Occupational Therapy
• Other Treatments
• 6.3. Global Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administration
• 6.4. Global Dupuytren's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Examination
• X-Ray
• Other Diagnosis
• 6.5. Global Dupuytren's Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Academic And Research Institute
• Other End-Users
• 6.6. Global Dupuytren's Disease Market, Sub-Segmentation Of By Type I, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Classical Dupuytren's Disease
• Familial Dupuytren's Disease
• 6.7. Global Dupuytren's Disease Market, Sub-Segmentation Of Type II, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Palmar Fasciitis
• Ledderhose Disease
• 6.8. Global Dupuytren's Disease Market, Sub-Segmentation Of Type III, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Garrod's Pads
• Peyronie's Disease

7. Dupuytren's Disease Market Regional And Country Analysis

• 7.1. Global Dupuytren's Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Dupuytren's Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dupuytren's Disease Market

• 8.1. Asia-Pacific Dupuytren's Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dupuytren's Disease Market

• 9.1. China Dupuytren's Disease Market Overview
• 9.2. China Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dupuytren's Disease Market

• 10.1. India Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dupuytren's Disease Market

• 11.1. Japan Dupuytren's Disease Market Overview
• 11.2. Japan Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dupuytren's Disease Market

• 12.1. Australia Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dupuytren's Disease Market

• 13.1. Indonesia Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dupuytren's Disease Market

• 14.1. South Korea Dupuytren's Disease Market Overview
• 14.2. South Korea Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dupuytren's Disease Market

• 15.1. Western Europe Dupuytren's Disease Market Overview
• 15.2. Western Europe Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dupuytren's Disease Market

• 16.1. UK Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dupuytren's Disease Market

• 17.1. Germany Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dupuytren's Disease Market

• 18.1. France Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dupuytren's Disease Market

• 19.1. Italy Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dupuytren's Disease Market

• 20.1. Spain Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dupuytren's Disease Market

• 21.1. Eastern Europe Dupuytren's Disease Market Overview
• 21.2. Eastern Europe Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dupuytren's Disease Market

• 22.1. Russia Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dupuytren's Disease Market

• 23.1. North America Dupuytren's Disease Market Overview
• 23.2. North America Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dupuytren's Disease Market

• 24.1. USA Dupuytren's Disease Market Overview
• 24.2. USA Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dupuytren's Disease Market

• 25.1. Canada Dupuytren's Disease Market Overview
• 25.2. Canada Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dupuytren's Disease Market

• 26.1. South America Dupuytren's Disease Market Overview
• 26.2. South America Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dupuytren's Disease Market

• 27.1. Brazil Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dupuytren's Disease Market

• 28.1. Middle East Dupuytren's Disease Market Overview
• 28.2. Middle East Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dupuytren's Disease Market

• 29.1. Africa Dupuytren's Disease Market Overview
• 29.2. Africa Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dupuytren's Disease Market Competitive Landscape And Company Profiles

• 30.1. Dupuytren's Disease Market Competitive Landscape
• 30.2. Dupuytren's Disease Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Aetna Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Mayo clinic Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Penn Medicine Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Mercy Health Overview, Products and Services, Strategy and Financial Analysis

31. Dupuytren's Disease Market Other Major And Innovative Companies

• 31.1. Endo Inc.
• 31.2. Resilience Orthopedics
• 31.3. Raleigh Orthopaedic
• 31.4. Hoag Orthopedic Institute
• 31.5. OSS Health
• 31.6. Connext Inc.
• 31.7. University of Utah Health
• 31.8. Ventoux Biosciences Inc.
• 31.9. Auxilium Pharmaceuticals
  • 31.10. 180 Life Sciences Corp.
• 31.11. Brigid Freyne MD
• 31.12. Nantong Jinghua Pharmaceutical Co. Ltd.
• 31.13. Sumitomo Dainippon Pharma Co. Ltd.
• 31.14. Actiza Pharmaceutical Private Limited
• 31.15. Spear Pharmaceuticals

32. Global Dupuytren's Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dupuytren's Disease Market

34. Recent Developments In The Dupuytren's Disease Market

35. Dupuytren's Disease Market High Potential Countries, Segments and Strategies

• 35.1 Dupuytren's Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Dupuytren's Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Dupuytren's Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer